Veraxa Biotech AG - Post de-SPAC (VRXA, VRXAW)

CIK 2079109 · other company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Veraxa Biotech AG - Post de-SPAC.

Recent SEC filings

FiledFormAccession number
Oct 29, 202640001829126-26-011778
Oct 21, 202640001829126-26-011387
Oct 15, 20266-K0001829126-26-011185
Sep 14, 202630001829126-26-010085
Sep 4, 20266-K0001829126-26-009752
Sep 4, 2026424B30001829126-26-009753
Sep 4, 2026424B30001829126-26-009754
Aug 31, 202640001829126-26-009544
Aug 31, 202640001829126-26-009543
Aug 24, 20266-K0001829126-26-009237
Aug 20, 202630001829126-26-009154
Aug 13, 2026SCHEDULE 13G/A0001167557-26-000206
Aug 10, 2026424B50001829126-26-008548
Aug 10, 2026424B50001829126-26-008547
Aug 6, 2026EFFECT9999999995-26-002577
Aug 6, 2026EFFECT9999999995-26-002591
Aug 5, 2026F-1/A0001829126-26-008399
Aug 5, 2026F-1/A0001829126-26-008400
Jul 31, 2026F-10001829126-26-008246
Jul 31, 2026F-10001829126-26-008247
Jul 31, 20266-K0001829126-26-008238
Jul 27, 20266-K0001829126-26-007854
Jul 27, 20266-K0001829126-26-007881
Jun 18, 20266-K0001829126-26-006695
Jun 16, 2026SCHEDULE 13D0002134838-26-000001